Symbol="GRTS"
AssetType="Common Stock"
Name="Gritstone Oncology Inc"
Description="Gritstone bio, Inc., a clinical-stage biotechnology company, is dedicated to developing tumor-specific cancer immunotherapies to combat various types of cancer and infectious diseases. The company is headquartered in Emeryville, California."
CIK="1656634"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="5858 HORTON STREET, SUITE 210, EMERYVILLE, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="145818000"
EBITDA="-125169000"
PERatio="None"
PEGRatio="None"
BookValue="1.201"
DividendPerShare="0"
DividendYield="0"
EPS="-1.19"
RevenuePerShareTTM="0.111"
ProfitMargin="0"
OperatingMarginTTM="-11.33"
ReturnOnAssetsTTM="-0.379"
ReturnOnEquityTTM="-0.956"
RevenueTTM="11680000"
GrossProfitTTM="-91458000"
DilutedEPSTTM="-1.19"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.643"
AnalystTargetPrice="8.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="15.92"
PriceToBookRatio="1.59"
EVToRevenue="12.36"
EVToEBITDA="-1.078"
Beta="0.518"
num_52WeekHigh="4.23"
num_52WeekLow="1.545"
num_50DayMovingAverage="2.04"
num_200DayMovingAverage="2.584"
SharesOutstanding="88914000"
DividendDate="None"
ExDividendDate="None"
symbol="GRTS"
open="1.69"
high="1.69"
low="1.54"
price="1.61"
volume="821552.00"
latest_trading_day="2023-08-21"
previous_close="1.64"
change="-0.03"
change_percent="-1.8293%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="88"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="12"
Volume_recent_avg="730254"
Change_recent_avg="-0.01"
Delta_recent_avg="0.16"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="-0.83"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="12"
Aroon_momentum_negative="88"
image_negative_thumbnail_id_1="1123"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0156.jpeg"
image_negative_thumbnail_id_2="131"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0045.jpeg"
image_neutral_thumbnail_id_1="537"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0062.jpeg"
image_neutral_thumbnail_id_2="543"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0056.jpeg"
image_positive_thumbnail_id_1="690"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0018.jpeg"
image_positive_thumbnail_id_2="952"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0114.jpeg"
image_professor_thumbnail_id_1="1198"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
image_professor_thumbnail_id_2="1167"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
